|Articles|June 8, 2020
Clinical Trials in the Wake of COVID-19
ACT’s Lisa Henderson interviews John Potthoff, PhD, CEO of Elligo Health Research, about decentralizing and restarting clinical trials amid the COVID-19 pandemic.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
Accelerate Inclusive Enrollment and Delivery with LightshipFebruary 19th 2025
Harmonizing Data in Clinical ResearchOctober 21st 2024
Parexel’s FSP: Evolving With Your Needs Now and in the FutureOctober 3rd 2024
Trending on Applied Clinical Trials Online
1
Subcutaneous Saphnelo Shows Positive Phase III Results in Systemic Lupus Erythematosus
2
Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19
3
ACT Brief: Policy Shifts, FDA Inspections, and Tariffs Pose New Challenges for Clinical Trials
4
Enhancing Clinical Trial Data Accuracy Through the IQVIA and Veeva Partnership
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
